H Furue

572 total citations
34 papers, 421 citations indexed

About

H Furue is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H Furue has authored 34 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H Furue's work include Cancer therapeutics and mechanisms (6 papers), Head and Neck Cancer Studies (6 papers) and Lung Cancer Treatments and Mutations (6 papers). H Furue is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Head and Neck Cancer Studies (6 papers) and Lung Cancer Treatments and Mutations (6 papers). H Furue collaborates with scholars based in Japan, Tunisia and Greece. H Furue's co-authors include Minoru Ueda, Toshio Shigetomi, H Niitani, T Taguchi, A Wakui, Kazuo Hasegawa, Shinji Mii, Noriyuki Yamamoto, Yoshiki Murakumo and Sumitaka Hagiwara and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

H Furue

30 papers receiving 401 citations

Peers

Countries citing papers authored by H Furue

Since Specialization

Citations

This map shows the geographic impact of H Furue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Furue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Furue more than expected).

Fields of papers citing papers by H Furue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Furue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Furue. The network helps show where H Furue may publish in the future.

Co-authorship network of co-authors of H Furue

This figure shows the co-authorship network connecting the top 25 collaborators of H Furue. A scholar is included among the top collaborators of H Furue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Furue. H Furue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Notch3 is frequently downregulated in oral cancer 2017 ·Journal of Oral and Maxillofacial Surgery Medicine and Pathology ·Norihisa Ichimura, Noriyuki Yamamoto, (unknown), H Furue, Yutaka Kondo, Hideharu Hibi	4
2	A case of arteriovenous malformation of the tongue that deteriorated during pregnancy 2016 ·Japanese Journal of Oral & Maxillofacial Surgery ·H Furue, Noriyuki Yamamoto, (unknown), Sumitaka Hagiwara, Hideharu Hibi	0
3	Pathological analysis of Ki-67 and CD109 expression in tongue squamous cell carcinoma 2012 ·Journal of Oral and Maxillofacial Surgery Medicine and Pathology ·Sumitaka Hagiwara, Noriyuki Yamamoto, H Furue, (unknown), Toshio Shigetomi, Yoshiki Murakumo, Hideharu Hibi, Masahide Takahashi, Minoru Ueda	2
4	A case of intraoral methotrexate-assosiated lymphoproliferative disorder 2011 ·Japanese Journal of Oral & Maxillofacial Surgery ·Takashi Hatanaka, Y. SAWAKI, J. Yamada, H Furue, (unknown), Minoru Ueda	9
5	Inverse association between toothbrushing and upper aerodigestive tract cancer risk in a Japanese population 2011 ·Head & Neck ·(unknown), Isao Oze, Daisuke Kawakita, Noriyuki Yamamoto, Hidemi Ito, Satoyo Hosono, Takeshi Suzuki, Takakazu Kawase, H Furue, Miki Watanabe, Shunzo Hatooka, Yasushi Yatabe, Yasuhisa Hasegawa, Masayuki Shinoda, Minoru Ueda, Kazuo Tajima, Hideo Tanaka, Keitaro Matsuo	37
6	Processing of CD109 by furin and its role in the regulation of TGF-β signaling 2010 ·Oncogene ·Sumitaka Hagiwara, Yoshiki Murakumo, Shinji Mii, Toshio Shigetomi, Norio Yamamoto, H Furue, Minoru Ueda, Masahide Takahashi	68
7	Organ Preservation With Daily Concurrent Chemoradiotherapy Using Superselective Intra-Arterial Infusion via a Superficial Temporal Artery for T3 and T4 Head and Neck Cancer 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Kenji Mitsudo, Toshio Shigetomi, Yasushi Fujimoto, (unknown), Noriyuki Yamamoto, H Furue, Minoru Ueda, Yoshiyuki Itoh, Nobukazu Fuwa, Iwai Tohnai	49
8	Limited but heterogeneous osteogenic response of human bone marrow mesenchymal stem cells to bone morphogenetic protein-2 and serum 2009 ·Growth Factors ·(unknown), Hideki Agata, H Furue, Ayuko Kimura, Yuji Narita, Nobukazu Watanabe, Yumiko Ishii, Minoru Ueda, Arinobu Tojo, Hideaki Kagami	18
9	Daily concurrent chemoradiotherapy with docetaxel (DOC) and cisplatin (CDDP) using superselective intra-arterial infusion via superficial temporal artery for T3 and T4 head and neck cancer: Possibility of organ preservation in advanced head and neck cancer 2009 ·Journal of Clinical Oncology ·Kenji Mitsudo, Toshio Shigetomi, (unknown), Takafumi Fukui, Norio Yamamoto, H Furue, Minoru Ueda, (unknown), Toshinori Iwai, Iwai Tohnai	2
10	Decreased risk of colorectal cancer with the high natural killer cell activity NKG2D genotype in Japanese 2008 ·Carcinogenesis ·H Furue, Keitaro Matsuo, Hiroshi Kumimoto, Akio Hiraki, Takeshi Suzuki, Yasushi Yatabe, Koji Komori, Yukihide Kanemitsu, Takashi Hirai, Tomoyuki Kato, Minoru Ueda, Kanji Ishizaki, Kazuo Tajima	43
11	Opposite impact of NKG2D genotype by lifestyle exposure to risk of aerodigestive tract cancer among Japanese 2008 ·International Journal of Cancer ·H Furue, Hiroshi Kumimoto, Keitaro Matsuo, Takeshi Suzuki, Yasuhisa Hasegawa, Masayuki Shinoda, T. Sugimura, Kenji Mitsudo, Iwai Tohnai, Minoru Ueda, Kazuo Tajima, Kanji Ishizaki	15
12	[LY188011 phase I study. Research Group of Gemcitabine (LY188011)]. 1996 ·PubMed ·Tetsuya Taguchi, Kiyoyuki Furuse, M. Fukuoka, Tatsu Shimoyama, (unknown), Tohru Nakamura, H Furue, H Majima, H Niitani, (unknown), A Wakui, I Nakao, Shigeru Tsukagoshi	5
13	[Phase I Study of RA-700. RA-700 Clinical Study Group]. 1993 ·PubMed ·H Majima, Shigeru Tsukagoshi, H Furue, (unknown), (unknown), Ryo Wakabayashi, Satoshi Kishino, H Niitani, Asuka Murata, (unknown)	5
14	[A phase I study of DWA2114R]. 1992 ·PubMed ·Y Ariyoshi, A Wakui, (unknown), H Niitani, Makoto Ogawa, Yoshihisa Sakai, H Majima, H Furue, (unknown), Takao Taguchi	2
15	[Phase I clinical study of CPT-11. Research group of CPT-11]. 1990 ·PubMed ·T Taguchi, A Wakui, Kazuo Hasegawa, H Niitani, H Furue, (unknown), (unknown)	58
16	[Phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Multi-Institutional Cooperative Study]. 1986 ·PubMed ·Tomomi Saito, (unknown), A Wakui, H Furue, H Majima, (unknown), Tadao Niijima, (unknown), (unknown), Yukihide Koyama	9
17	[Phase I study of 5'-deoxy-5-fluorouridine (5'-DFUR)]. 1985 ·PubMed ·I Nakao, T Saito, Kazuhiro Kimura, A Wakui, M. Yokoyama, Rihito Kanamaru, H Furue, (unknown), (unknown), (unknown)	2
18	Randomized clinical study with MMC and 5-FU vs MMC, 5-FU and PSK in advanced gastric cancer 1985 ·International Journal of Immunopharmacology ·I Nakao, Takashi Yokoyama, I Urushizaki, A Wakui, H Furue, (unknown), Kiyoji Kimura, Narihito Ogawa, (unknown)	1
19	[Clinical evaluation of SPG (schizophyllan) as a therapeutic adjuvant after surgery of gastric cancer--controlled study by an envelope method]. 1983 ·PubMed ·Shigeru Fujimoto, (unknown), T. Kimura, Tatsuhei Kondo, Takao Taguchi, Ken Yoshida, (unknown), H Furue	22
20	[Clinical experiences with PC-B-45]. 1969 ·PubMed ·Tomohiro Kurokawa, (unknown), H Furue, I Nakao, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact